Sign In
ShareFostemsavir (Rukobia) Pill Preview

Fostemsavir (Rukobia)

Other Names: FTR

All Clinical Trials

Filter by Category
  • All Clinical Trials
  • Clinical Studies
    • Treatment-Naive
    • Treatment-Experienced
    • Switch/Simplification
    • Dual Therapy
    • Monotherapy
    • PREP
    • PEP
    • Acute HIV
  • Resistance/Virological Failure
  • Pharmacology
    • General Pharmacology
    • Adverse Effects
    • Drug Interactions
  • Pregnancy/Women
  • Pediatrics
  • Review
BRIGHTE Industry
Official Title A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1
Purpose / DescriptionPhase III
Phase Phase III
ClinicalTrials.gov NCT02362503
Treatments
Fostemsavir
Fostemsavir Rukobia

Fostemsavir

Tradename:RukobiaOther Names:FTRClass:Entry Inhibitors
Categories Resistance/Virological FailureTreatment-Experienced
Funding
IndustryBristol-Myers Squibb
References
  • Kozal M, Aberg J, Pialoux G, et al. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2020;382:1232-43.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.